Genetic Engineering & Biotechnology News (GEN) features VALIDOGEN’s perspective on the importance of early bioprocess development for biotech startups.
VALIDOGEN experts Rosie Maddock and Iskandar Dib emphasize that early investment in process design considering Quality by Design principles and scalability,can prevent costly setbacks during GMP production. With diverse molecule formats becoming more common, startups are encouraged to build process knowledge early and leverage external expertise to ensure long-term success.
Read the full article: Small Biotechs Should Develop Bioprocesses Early